The Medicines Co (MDCO)
84.11
-0.11 -0.13%
NASDAQ
Dec 11, 11:34
Delayed 2m
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | -- |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | -3.10 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | -236.39M |
Profitability | |
Gross Profit Margin (Quarterly) | -- |
Profit Margin (Quarterly) | -- |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield (TTM) | 0% |
Price and Valuation | |
Market Cap | 6.723B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio (TTM) | 432.44 |
PE Ratio (TTM) | -- |
Price to Book Value | -- |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio (Quarterly) | -- |
Free Cash Flow (Quarterly) | -60.71M |
Return on Equity (TTM) | Upgrade |
View All MDCO News
News
-
WireHeadlineTime (ET)
-
Globe Newswire12/10 21:30
-
Yahoo12/10 18:30
-
Yahoo12/10 16:16
-
Globe Newswire12/10 11:46
-
Yahoo12/09 13:30
-
Yahoo12/07 14:04
-
Yahoo12/05 15:50
-
Yahoo12/05 15:44
-
Yahoo12/04 10:45
-
Globe Newswire12/04 08:00
View All Events
Events
Date | Type | Description |
---|---|---|
02/27/2020 08:30 EST | Misc | The Medicines Co Fourth Quarter Earnings Conference Call in 2019 |
02/27/2020 | Earnings | The Medicines Co Fourth Quarter Earnings in 2019 Release |
10/30/2019 08:30 EDT | Misc | The Medicines Co Third Quarter Earnings Conference Call for 2019 |
10/30/2019 | Earnings | The Medicines Co Third Quarter Earnings in 2019 Release |
07/24/2019 08:30 EDT | Misc | The Medicines Co Second Quarter Earnings Conference Call in 2019 |
07/24/2019 | Earnings | The Medicines Co Second Quarter Earnings in 2019 Release |
05/30/2019 | Misc | The Medicines Co Annual General Meeting in 2018 |
04/25/2019 08:30 EDT | Misc | The Medicines Co First Quarter Earnings Conference Call in 2019 |
04/25/2019 | Earnings | The Medicines Co First Quarter Earnings in 2019 Release |
02/27/2019 08:30 EST | Misc | The Medicines Co Fourth Quarter Earnings Conference Call in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.themedicinescompany.com
- Investor Relations URL: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-irhome
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Feb. 27, 2020
- Last Earnings Release: Oct. 30, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 84.11 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
MNA | IQ Merger Arbitrage ETF | 7.32% |
PHSRX | Putnam Global Health Care R | 4.70% |
EAFRX | First Eagle Fund of America R4 | 3.64% |
HRSGX | Harbor Small Cap Growth Admin | 3.02% |
TOECX | Touchstone Mid Cap Growth C | 2.79% |
XBI | SPDR® S&P Biotech ETF | 2.55% |
HGHVX | Hartford Healthcare R6 | 1.70% |
IJT | iShares S&P Small-Cap 600 Growth ETF | 1.26% |
IBB | iShares Nasdaq Biotechnology ETF | 0.90% |
IJR | iShares Core S&P Small-Cap ETF | 0.81% |
VTSIX | Vanguard Tax-Managed Small Cap I | 0.51% |
IWM | iShares Russell 2000 ETF | 0.31% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MDCO Tweets Stocktwits
Advertisement